NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,825 | -1.1% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,904 | +0.5% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,872 | +13.1% | 67 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,078 | +21.6% | 67 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $5,000 | -16.7% | 67 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | 0.0% | 67 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | +100.0% | 67 | +67.5% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | -66.7% | 40 | -60.0% | 0.00% | -66.7% |
| Q4 2017 | $9,000 | -79.1% | 100 | -80.0% | 0.01% | -79.3% |
| Q3 2017 | $43,000 | +2.4% | 500 | 0.0% | 0.03% | +3.6% |
| Q2 2017 | $42,000 | +90.9% | 500 | +66.7% | 0.03% | +75.0% |
| Q1 2017 | $22,000 | 0.0% | 300 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $22,000 | – | 300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 175,039 | $14,610,000 | 5.98% |
| MANAGED ASSET PORTFOLIOS, LLC | 211,640 | $17,665,000 | 5.83% |
| PRENTISS SMITH & CO INC | 128,894 | $10,759,000 | 5.63% |
| SECTORAL ASSET MANAGEMENT INC | 559,296 | $46,684,000 | 5.10% |
| Osher Van de Voorde Investment Management | 106,515 | $8,891,000 | 4.74% |
| BROWN BROTHERS HARRIMAN & CO | 10,150,549 | $847,266,000 | 4.59% |
| Elefante Mark B | 6,019 | $502,000 | 4.06% |
| PROFESSIONAL ADVISORY SERVICES INC | 223,738 | $18,675,000 | 4.05% |
| First Fiduciary Investment Counsel, Inc. | 245,403 | $20,484,000 | 3.92% |
| COMPASS CAPITAL MANAGEMENT, INC | 282,530 | $23,583,000 | 3.84% |